Anti-CXCL10 Recombinant Antibody (Eldelumab) (CAT#: TAB-742)

Recombinant human monoclonal antibody expressed in CHO binding to human CXCL10. Eldelumab is a monoclonal antibody designed for the treatment of Crohn's disease and ulcerative colitis.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, IHC and most other immunological methods.
  • CAS
  • 946414-98-8
  • Generic Name
  • eldelumab
  • MW
  • 146.5 kDa
  • Related Disease
  • Rheumatoid arthritis (RA)

Product Property

  • Purity
  • >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
  • Storage
  • 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.

Target

  • Alternative Names
  • eldelumab;946414-98-8;MDX-1100;BMS-936557;CXCL10;chemokine (C-X-C motif) ligand 10;INP10, SCYB10, small inducible cytokine subfamily B (Cys X Cys), member 10;C-X-C motif chemokine 10;C7;crg 2;gIP 10;IFI10;IP 10;mob 1;gamma IP10;gamma-IP10;small-inducible

Related Resources

  • Biosimilar Overview
  • Related Signaling Pathways
Please refer to Eldelumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Eldelumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Eldelumab"

Afuco™ Anti-CXCL10 ADCC Recombinant Antibody (Eldelumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human CXCL10. Eldelumab is a monoclonal antibody designed for the treatment of Crohn's disease and ulcerative colitis.

See other products for "CXCL10"

Human Antibody

CAT Product Name Application Type
TAB-198CL Human Anti-CXCL10 Recombinant Antibody (TAB-198CL) ELISA Human IgG

Chicken IgY Antibody

CAT Product Name Application Type
BRD-0147MZ Chicken Anti-CXCL10 Polyclonal IgY indirect ELISA, WB Chicken antibody

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-742 Afuco™ Anti-CXCL10 ADCC Recombinant Antibody (Eldelumab), ADCC Enhanced IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-742. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare